Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Prostatic Neoplasms 3Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Rectal Neoplasms 1Radiation-induced Injuries in Patients With Rectal Cancer 1Radiation Injuries 1Precancerous Conditions 1Neoplasms, Second Primary 1Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Head and Neck Fibrosis 1Fibrosis 1Erectile Dysfunction 1Colorectal Neoplasms 1Adenomatous Polyps 1

Interventions

Drug Therapy 3Temozolomide 2Radiotherapy 2Radiosurgery 2Leucovorin 2Irinotecan 2Fluorouracil 2sacubitril and valsartan sodium hydrate drug combination 1icotinib 1dostarlimab 1beta Carotene 1avelumab 1alpha-Tocopherol 1Varenicline 1Tyrosine Kinase Inhibitors 1Trastuzumab 1Tobacco Use Cessation Devices 1Therapeutics 1Thalidomide 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Semen Analysis 1Registries 1Probiotics 1Patient Reported Outcome Measures 1Panitumumab 1Nicotine Chewing Gum 1Myofascial Release Therapy 1Megestrol Acetate 1Lenalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Second Primary × alpha-Tocopherol × Clear all
NCT00169845 2018-03-14

Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients

Laval University

Phase 3 Completed
540 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Radiation Injuries, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡